Franklin Resources’s Caribou Biosciences CRBU Stock Holding History

Franklin Resources’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-12,411	Closed	-$19.7K	–	2983
2024 Q4	$19.7K	Buy	12,411 +120	+1%	+$241	﹤0.01%	2856
2024 Q3	$23.4K	Buy	+12,291	New	+$25.2K	﹤0.01%	2843
2024 Q2	–	Sell	-50,962	Closed	-$262K	–	2886
2024 Q1	$262K	Sell	50,962 -329	-0.6%	-$2.03K	﹤0.01%	2506
2023 Q4	$294K	Buy	51,291 +36,657	+250%	+$181K	﹤0.01%	2182
2023 Q3	$70K	Sell	14,634 -34	-0.2%	-$211	﹤0.01%	2499
2023 Q2	$62.3K	Sell	14,668 -174	-1%	-$782	﹤0.01%	2594
2023 Q1	$78.8K	Buy	14,842 +101	+0.7%	+$629	﹤0.01%	2139
2022 Q4	$92.6K	Buy	14,741 +73	+0.5%	+$650	﹤0.01%	2138
2022 Q3	$155K	Buy	14,668 +188	+1%	+$1.75K	﹤0.01%	2028
2022 Q2	$79K	Sell	14,480 -6,970	-32%	-$53.3K	﹤0.01%	2183
2022 Q1	$197K	Buy	+21,450	New	+$226K	﹤0.01%	2163

Other funds holding CRBU

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources's CRBU Position: Q1 2025 in Review

Franklin Resources sold out of Caribou Biosciences (CRBU) in Q1 2025, closing a stake of 12,411 shares — an estimated $19.7K sold.

Franklin Resources first reported a position in CRBU in Q1 2022 and held it in 11 quarters. The position peaked at $294K in Q4 2023. 131 funds tracked by Wall St. Rank hold CRBU as of Q1 2025.

Franklin Resources reported no remaining Caribou Biosciences position as of Q1 2025 after selling out during the quarter.
Franklin Resources sold 12,411 Caribou Biosciences shares in Q1 2025, an estimated $19.7K.
Franklin Resources first reported a position in Caribou Biosciences in Q1 2022 and held it in 11 quarters.
Franklin Resources's Caribou Biosciences position peaked at $294K in Q4 2023.
131 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2025.

Based on Franklin Resources's 13F filing for Q1 2025, filed 13 May 2025.